An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 63, Issue 5, Pages 1632-1639
Publisher
Wiley
Online
2015-11-04
DOI
10.1002/hep.28332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial
- (2015) Salvatore Piano et al. HEPATOLOGY
- The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey
- (2015) Manuela Merli et al. PLoS One
- Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour
- (2014) Ricard Ferrer et al. CRITICAL CARE MEDICINE
- Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
- (2014) Rajiv Jalan et al. JOURNAL OF HEPATOLOGY
- Epidemiology and outcomes of bloodstream infection in patients with cirrhosis
- (2014) Michele Bartoletti et al. JOURNAL OF HEPATOLOGY
- Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome
- (2014) Konstantina Sargenti et al. LIVER INTERNATIONAL
- New determinants of prognosis in bacterial infections in cirrhosis
- (2014) Juan Acevedo WORLD JOURNAL OF GASTROENTEROLOGY
- Outcomes of Patients Hospitalized With Community-Acquired, Health Care–Associated, and Hospital-Acquired Pneumonia
- (2013) Mario Venditti ANNALS OF INTERNAL MEDICINE
- Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012
- (2013) Bruce A. Runyon HEPATOLOGY
- Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis
- (2013) Alexandra Alexopoulou et al. LIVER INTERNATIONAL
- Bacterial resistance in cirrhotic patients: An emerging reality
- (2012) Manuela Merli et al. JOURNAL OF HEPATOLOGY
- Management of bacterial infections in cirrhosis
- (2012) Javier Fernández et al. JOURNAL OF HEPATOLOGY
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
- (2011) Javier Fernández et al. HEPATOLOGY
- Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis
- (2011) Xavier Ariza et al. JOURNAL OF HEPATOLOGY
- Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections
- (2010) Manuela Merli et al. Clinical Gastroenterology and Hepatology
- Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
- (2010) Anand Kumar et al. CRITICAL CARE MEDICINE
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
- (2010) JOURNAL OF HEPATOLOGY
- Severe sepsis in cirrhosis
- (2009) Thierry Gustot et al. HEPATOLOGY
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis
- (2008) Puneeta Tandon et al. SEMINARS IN LIVER DISEASE
- Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice
- (2008) Stefania Angeloni et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started